Comparative performance of the Biocentric Generic Viral Load, Roche CAP/CTM v1.5, Roche CAP/CTM v2.0 and m2000 Abbott assays for quantifying HIV-1 B and non-B strains: Underestimation of some CRF02 strains

Comparative performance of the Biocentric Generic Viral Load, Roche CAP/CTM v1.5, Roche CAP/CTM v2.0 and m2000 Abbott assays for quantifying HIV-1 B and non-B strains: Underestimation of some CRF02 strains. Avettand-Fénoël, V.; Mélard, A.; Gueudin, M.; Maillard, A.; Dina, J.; Gousset, M.; Chaix, M. L.; Lerolle, N.; Viard, J. P.; Meyer, L.; Plantier, J. C.; Rouzioux, C.; ANRS-AC11 HIV Quantification Working Group. Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology. 2019; 110: p.36-41. doi:10.1016/j.jcv.2018.12.002
Article